drugset / Trial / NCT02011971

Cognitive Effects of Vinpocetine in Healthy Adults and Patients With Epilepsy

NCT02011971

Phase 1/2 Suspended 30 enrolled Stanford University
RandomizedCrossoverQuadruple-blindTreatment

Summary

Pilot studies in healthy volunteers and in patients with epilepsy to assess the potential efficacy and safety of different dosages of vinpocetine in improving cognition.

Timeline

Start
2012-02
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vinpocetine Small molecule 10 mg Oral
Comparator Vinpocetine Small molecule 20 mg Oral
Comparator Vinpocetine Small molecule 60 mg Oral

Indications